Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?

書目詳細資料
發表在:	EBioMedicine
Main Authors:	Ramachandran Vignesh, Esaki M. Shankar
格式:	Article
語言:	英语
出版:	Elsevier 2017-10-01
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2352396417303420

相似書籍

24 Thalidomide reverses latency of HIV-1 provirus
由: S. Samer, et al.
出版: (2016-07-01)

Latency Reversing Agents and the Road to an HIV Cure
由: Louis Tioka, et al.
出版: (2025-02-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
由: Shane D. Falcinelli, et al.
出版: (2019-12-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
由: L. Pache, et al.
出版: (2019-12-01)

Evil and Guilt: on Original Sin and Ancestral Sin
由: Marcelo López Cambronero
出版: (2023-12-01)

HIV-1 latency reversal agent boosting is not limited by opioid use
由: Tyler Lilie, et al.
出版: (2024-11-01)

NSC95397 Is a Novel HIV-1 Latency-Reversing Agent
由: Randilea Nichols Doyle, et al.
出版: (2024-11-01)

Optimal Control of an HIV Model with Gene Therapy and Latency Reversing Agents
由: Zachary Abernathy, et al.
出版: (2021-11-01)

HIV Tat as a latency reversing agent: turning the tables on viral persistence
由: Bridget M. Fisher, et al.
出版: (2025-04-01)

HIV latency reversing agents act through Tat post translational modifications
由: Georges Khoury, et al.
出版: (2018-05-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
由: G. Clutton, et al.
出版: (2015-12-01)

The HIV latency reversing agent HODHBt inhibits the phosphatases PTPN1 and PTPN2
由: J. Natalie Howard, et al.
出版: (2024-09-01)

Epigenetic Regulation of HIV-1 Sense and Antisense Transcription in Response to Latency-Reversing Agents
由: Rui Li, et al.
出版: (2023-01-01)

Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells
由: Melanie Dimapasoc, et al.
出版: (2024-04-01)

Molecular Modeling and Synthesis of New HIV Latency-Reversing Agents Targeting the Lymphatic System
由: Beatriz Meduqui Rodrigues, et al.
出版: (2022-11-01)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.
由: Vipul Gupta, et al.
出版: (2018-02-01)

New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency Prevention
由: Catherine A. Lewis, et al.
出版: (2023-07-01)

Ethnopharmacological exploration and isolation of HIV-1 latency-reversing agents from Sudanese medicinal plants
由: Khaled M. Elamin, et al.
出版: (2025-08-01)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
由: Thanarat Salahong, et al.
出版: (2021-05-01)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
由: Katherine M. Bricker, et al.
出版: (2021-08-01)

PP 5.4 – 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
由: L. Pache, et al.
出版: (2022-12-01)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
由: Gilles Darcis, et al.
出版: (2016-05-01)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen.
由: Hongbing Liu, et al.
出版: (2021-01-01)

Impact of latency‐reversing agents on human macrophage physiology
由: Laurent Hany, et al.
出版: (2023-01-01)

Are we prepared to save the sanctity of science from predatory journals?
由: Vignesh Ramachandran, et al.
出版: (2019-01-01)

The Rational Combination Strategy of Immunomodulatory Latency Reversing Agents and Novel Immunotherapy to Achieve HIV-1 Cure
由: Yangyang Li, et al.
出版: (2022-10-01)

The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells
由: Dennis C. Copertino Jr., et al.
出版: (2023-09-01)

Reanalysis of Gene Expression Profiles of CD4+ T Cells Treated with HIV-1 Latency Reversal Agents
由: Antonio Victor Campos Coelho, et al.
出版: (2020-09-01)

Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
由: Khumoekae Richard, et al.
出版: (2018-06-01)

Anti-latency agents to purge HIV reservoirs
由: Moreno Santiago
出版: (2012-05-01)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
由: Renée M Van der Sluis, et al.
出版: (2020-02-01)

HIVGKO: A Tool to Assess HIV-1 Latency Reversal Agents in Human Primary CD4+ T Cells
由: Emilie Battivelli, et al.
出版: (2018-10-01)

Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression
由: Gislaine Curty, et al.
出版: (2022-07-01)

Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
由: Daniela Angela Covino, et al.
出版: (2022-11-01)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
由: Gilles Darcis, et al.
出版: (2016-09-01)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
由: Quinten Debrabander, et al.
出版: (2023-09-01)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
由: Donya Naz Divsalar, et al.
出版: (2020-06-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
由: Sushant Khanal, et al.
出版: (2021-02-01)

Lymphoid tissue and blood CD4 T cells respond differently to latency-reversing agents: are we testing the right cells?
由: A. Gramatica, et al.
出版: (2015-12-01)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
由: Adam Ward, et al.
出版: (2017-07-01)